Back
AnaptysBio Vs. Viking Therapeutics Industry Stock Comparison
Buy
58
ANAB
AnaptysBio
Last Price:
34.83
Seasonality Move:
26.98%
Buy
57
VKTX
Viking Therapeutics
Last Price:
61.94
Seasonality Move:
36.82%
Buy
58
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $34.81. The Score for ANAB is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.94. The Score for VKTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $34.81
The current trend is moderately bearish and ANAB is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.94
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | -59843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.73 - 38.23) | Sell |
| Bollinger Bands (100): | (24.6 - 36.04) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 49.92 | Sell |
| Chaikin Money Flow: | -2736031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.11 - 66.75) | Sell |
| Bollinger Bands (100): | (52 - 67.82) | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.44 | Sell |
| 20-day SMA: | 36.91 | Sell |
| 50-day SMA: | 35.72 | Sell |
| 200-day SMA: | 26.39 | Buy |
| 8-day EMA: | 36.66 | Sell |
| 20-day EMA: | 36.64 | Sell |
| 50-day EMA: | 34.71 | Buy |
| 200-day EMA: | 27.93 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.86 | Sell |
| 20-day SMA: | 61.77 | Buy |
| 50-day SMA: | 59.15 | Buy |
| 200-day SMA: | 53.24 | Buy |
| 8-day EMA: | 64.59 | Sell |
| 20-day EMA: | 62.78 | Sell |
| 50-day EMA: | 60.57 | Buy |
| 200-day EMA: | 51.71 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.06 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
AnaptysBio Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||